Wednesday, October 5, 2022

Insulin & Analogs: Options, Formulations, and Efficacy

Dear Dr. Renukaprasad A R,
The advances in recombinant DNA technologies have led to both rapid- and long-acting human insulin analogs administered via the subcutaneous route, which better mimics the physiology of insulin secretion, leading to the modern basal-bolus regimen. This enables people with diabetes to meet their individual glycemic goals effectively.
On the occasion of our 9th anniversary, we bring you an exclusive DIWAS session on "Insulin and its Analogs: Options, Formulations, and Efficacy" by experts in the field. Join us on 6th October 2022, 6:00 PM IST onwards!
Speaker: Dr. Lakshmi Hariharan
Topic: Insulin- Options and formulations
Session Highlights: 
  • Types of insulin 
  • Physiology of insulin secretion 
  • Short-acting and long-acting analogs 
Speaker: Dr. J S Kumar
Topic: Insulin analogs: Efficacy, pros and cons
Session Highlights: 
  • Basal insulin analogs 
  • Pre-mix insulin analogs 
  • Value of insulin analogs
Docplexus is one of the world's Largest online communities
Pune - 411045, India
info@docplexus.co.in�� |� +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

No comments:

Post a Comment